AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

CK Wang, MD, chief medical officer of COTA, discusses how real-world data help identify disparities and gaps in cancer care.

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

In CNS research, where qualitative endpoint variability can significantly affect a trial’s outcome, the role of eCOA is ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for ...

AI-powered autonomous trucks from Plus Automation are being tested across the U.S., Europe and Asia to solve logistics challenges while facing regulatory hurdles and labor concerns.

A panelist discusses how real-world experience with ruxolitinib and belumosidil shows similar response rates to clinical ...

Australia: A recent multicentre audit conducted in Queensland, Australia, has provided compelling real-world evidence ...

In an exhibition at this year’s Belfast Photo Festival, Antón exhibits imagery based on real testimony from the 17th century ...

Research reveals major gap between weight-loss surgery and GLP-1 drugs, with real-world results of injectable medications falling short of clinical trial outcomes.

UNDATED (WKRC) - Weight-loss medications may not be as effective in "real-world" settings as they are in clinical trials, ...